ArticleAIDS and behavior2026
National HIV Behavioral Surveillance Among Women of Transgender Experience and Transfeminine People in Nine Cities in the United States, 2023-2024.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Decade of Improvement and Signs of Decline in PrEP Awareness and Use in Young Trans Women.AIDS and behavior · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Women of transgender experience and transfeminine people (WTE/TFP) are disproportionately impacted by HIV. Between July 2023 and May 2024, a total of 2059 eligible WTE/TFP across nine project areas participated in the National HIV Behavioral Surveillance (NHBS-Trans) project. Among the 1993 participants with valid HIV test results, 35.7% were living with HIV. Detrimental social and economic factors were common, including low income (57.0%), unemployment (35.4%), homelessness (31.8%), physical abuse and harassment (25.1%), and avoiding seeking healthcare due to discrimination (22.4%). Continued efforts to increase access to HIV testing and prevention strategies are vital to decrease the number of new infections to end the HIV epidemic. However, without increased access to economic opportunities and stable housing and decreases in discrimination and harassment, existing HIV prevention and care services may not address the HIV epidemic among women of transgender experience and transfeminine people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.